US agreement clarifies the use of stem cells in research

Agreement enables basic stem cell research to continue but bans diagnostic or therapeutic applications.

Written byTabitha Powledge
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

MARYLAND – Access for US scientists to human embryonic stem cells appears to be improving thanks to an agreement negotiated earlier this month by the National Institutes of Health (NIH) and the WiCell Research Institute, Inc., Madison, Wisconsin — a non-profit organization established in October 1999 to advance research in the area of stem cells. The agreement sets out the terms under which researchers can obtain and use the five WiCell cell lines developed before 9 August 2001, which US President George W. Bush has said are ethically acceptable for federally funded research. The need for the agreement is demonstrated by the fact that WiCell is currently receiving 10 to 15 requests for the cell lines every day.

The new agreement specifies that the cells can be used only for non-commercial research and teaching. But the NIH, not WiCell, will retain ownership of any new intellectual property arising from that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA